Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 inhibitor plus metronomic chemotherapy for MSS advanced colorectal cancer
ChiCTR2000032079Phase 4Recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorouracil, raltitrexed and irinotecan in colorectal cancer (CRC), sponsored by The Seventh Affiliated Hospital, Sun Yat-Sen University. Primary endpoints: Overall survival and Progression-free survival. Started Apr 2020; status: recruiting.
02
Drugs
fluorouracilraltitrexedirinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000032079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032079.